Previous studies have reported that targeting HDAC6 alleviates the phenotypes of multiple neurodegenerative mouse models,73 including AD,35, 40, 74 amyotrophic lateral sclerosis (ALS),75 and Charcot‐Marie‐Tooth disease (CMT2D).76, 77. This evidence concerns the gene HDAC6 and Alzheimer disease.